How will the regulation of nanotechnology develop? Clues from other sectors

New Global Frontiers in Regulation: The Age of Nanotechnology

Volumn , Issue , 2007, Pages 353-381

  Bowman, Diana ^a   Gilligan, George ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67449153902     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (100)

1. Abraham, J. and T. Reed (2001), 'Trading risks for markets: the international harmonisation of pharmaceuticals', Health, Risk & Society, 3 (1), 113-28.
2. Anon (1992), 'ICH progress so far', Scrip, 1708, 14-15.
3. Asia Pacific Laboratory Accreditation Cooperation (APLAC) (2003), 'Focus: the establishment and development of Taiwan Accreditation Foundation (TAF)', APLAC News Notes, 69, 1-8.
4. Ayres, I. and J. Braithwaite (1992), Responsive Regulation: Transcending the Deregulation Debate, New York: Oxford University Press.
5. Baldwin, R. (1997), 'Regulation: after command and control', in K. Hawkins (ed.), The Human Face of Law, Oxford: Oxford University Press.
6. Baldwin, R. and M. Cave (1999), Understanding Regulation: Theory, Strategy, and Practice, Oxford: Oxford University Press.
7. BASF (2004), 'Code of conduct for nanotechnology', accessed 12 July 2006 at www.corporate.basf.com/en/sustainability/dialog/nanotechnologie/verhaltenskodex.htm?id=9SYDc8wF5bcp39E.
8. Berkeley City Council (2006), 'Agenda - Berkeley City Council meeting', 5 December, Berkeley, CA: Berkeley City Council.
9. Black, J. (2002), 'Critical Reflections on Regulation', Australian Journal of Legal Philosophy, 27, 1-29.
10. Black, J. (2001), 'Decentring regulation: the role of regulation and self-regulation in a "post regulatory" world', Current Legal Problems, 54, 103.
11. Black, J. (1998), 'Regulation as facilitation: negotiating the genetic revolution', Modern Law Review, 61, 621-60.
12. Boulton, M. (2006), 'Drug with a nasty past becomes a weapon in cancer fight', The Age, 18 January, 3.
13. Bowman, D. (2007), 'Patently obvious: intellectual property rights and nanotechnology', Technology in Society, 29 (3), 307-15.
14. Bowman, D. M. and G. A. Hodge (2007), 'Nanotechnology products in Australia: chemicals, cosmetics and regulatory character', Chapter 12, this volume.
15. Braithwaite, J. and P. Drahos (2000), Global Business Regulation, Melbourne: Cambridge University Press.
16. Christouforou, T. (n.d.), 'The precautionary principle, risk assessment, and the comparative role of science', as cited in D. Vogel (2003), The Politics of Risk Regulation in Europe and the United States, London: The Yearbook of European Environmental Law.
17. Clorox (2006), 2006 Annual Report, Oakland, CA: The Clorox Company.
18. Davies, J. C. (2006), Managing the Effects of Nanotechnology, Washington, DC: Woodrow Wilson International Center for Scholars.
19. Department of Environment Food and Rural Affairs (2006a), Consultation on a Proposed Voluntary Reporting Scheme for Engineered Nanoscale Materials, London: Defra.
20. Department of Environment Food and Rural Affairs (2006b), UK Voluntary Reporting Scheme for Engineered Nanoscale Materials, London: Defra.
21. Drahos, P. (2001), Bilateralism in Intellectual Property, London: Oxfam.
22. DuPont (2006), 2005 DuPont Data Book, US: DuPont.
23. Einsiedel, E. F. and L. Goldenberg (2004), 'Dwarfing the social? Nanotechnology lessons from the biotechnology front', Bulletin of Science, Technology & Society, 24 (1), 28-33.
24. Elliott, E. D. (2005), 'Regulate nano now', The Environmental Forum, July/ August, 43.
25. Environmental Protection Agency (2005a), Considerations Relevant to the Toxic Substance Control Act (TSCA) Application to Nanoscale Materials, Docket Detail: OPPT-2004-0122, Washington, DC: EPA.
26. Environmental Protection Agency (2005b), 'Nanoscale materials: notice of public meeting - docket detail: OPPT-2004-0122', Federal Register, 22 June.
27. Environmental Protection Agency (2006a), Letter of Invitation for a Stewardship Program, 18 October, Washington, DC: Office of Prevention, Pesticides and Toxic Substances, EPA.
28. Environmental Protection Agency (2006b), EPA Invites Public Participation in Development of Nanotechnology Stewardship Program, Washington, DC: EPA.
29. ETC Group (2007), 'Winners of nano-hazard symbol contest announced at World Social Forum, Nairobi, Kenya', ETC Group news release, accessed 15 January at www.etcgroup.org/upload/publication/604/02/wsffinalcontestjan24_07.pdf.
30. ETC Group (2002), 'No small matter! Nanotech particles penetrate living cells and accumulate in animal organs', communiqué issue no.76, Ottawa: ETC Group.
31. ETC Group (2003), The Big Down: Atomtech - Technologies Converging at the Nano-scale, Ottawa: ETC Group.
32. ETC Group (2004a), Down on the Farm, Ottawa: ETC Group.
33. ETC Group (2004b), 'Nanotech: unpredictable and un-regulation: new report from the ETC Group', news release, Ottawa: ETC Group.
34. European Commission (2004), Towards a European Strategy for Nanotechnology - Communication from the Commission COM (2004) 338, Brussels: European Commission.
35. European Commission (2005), Nanotechnology: Proceedings of the Workshop Research Needs on Nanoparticles, Brussels: European Commission.
36. European Commission (2005), 'Exploratory meeting for "responsible" research and development in nanotechnology - Chairman's conclusions', Brussels: European Commission and IDRRDN, accessed at www.cordis.lu/nanotechnology/src/ intldialogue.htm, 4 October 2006.
37. Food and Drug Administration (FDA) (2006), 'FDA forms internal nanotechnology task force', news release, 9 August, Washington, DC.
38. Foresight Nanotech Institute (2006), 'Advancing beneficial nanotechnology', accessed at www.foresight.org/, 12 July.
39. Friends of the Earth (2006a), Nanomaterials, Sunscreens and Cosmetics: Small Ingredients, Big Risks, Sydney: Friends of the Earth Australia and Friends of the Earth United States.
40. Friends of the Earth (2006b), An Analysis by Friends of the Earth of the National Nanotechnology Strategy Taskforce Report: 'Options for a National Nanotechnology Strategy', Melbourne: Friends of the Earth Australia Nanotechnology Project.
41. Fullam, B. (2005), 'Working with nanotechnology', paper presented at the UK/Japan Workshop on Health, Environmental and Societal Issues of Nanotechnologies, London: Royal Society and Science Council of Japan.
42. Gilligan, G. (2006), 'Prospects for the global regulation of markets', in G. Hodge (ed.), Privatization and Market Development: Global Movements in Public Policy Ideas, Northampton, MA and Cheltenham, UK: Edward Elgar, pp. 148-75.
43. Greenpeace (2003), Future Technologies, Today's Choices: Nanotechnology, Artificial Intelligence and Robotics; A Technical, Political and Institutional Map of Emerging Technologies, London: University of London and Greenpeace Environmental Trust.
44. Grove-White, R., M. Kearnes, P. Macnaghten, P. Miller, J. Wilsdon and B. Wynne (2004), Bio-to-Nano? Learning the Lessons, Interrogating the Comparison, London: Institute for Environment, Philosophy and Public Policy, Lancaster University.
45. Halliwell, C. (2005), 'An overview of nanotechnology initiatives in the EU', paper presented at the UK/Japan Workshop on Health, Environmental and Societal Issues of Nanotechnologies, London:Royal Society and Science Council of Japan.
46. HM Government (2005), The Government's Outline Programme for Public Engagement on Nanotechnologies, London: HM Government in consultation with the Devolved Administrations.
47. Hough, P. (2003), 'Poisons in the system: the global regulation of hazardous pesticides', Global Environment Politics, 3 (2), 11-24.
48. Intel (2006), 2005 Annual Report, Santa Clara, CA: Intel Corporation.
49. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use (2006), 'Structure: history and function', accessed at www.ich.org/UrlGrpServer.jser?@_ID=276&@_TEMPLATE=254, 23 January.
50. International Council on Nanotechnology (2005a), 'Nano coalition unveils environmental, health and safety database', accessed at www.icon.rice.edu/, 19 December.
51. International Council on Nanotechnology (2005b), 'ICON mission statement', accessed at www.icon.rice.edu/about.cfm?doc_id=4379, 12 December.
52. International Council on Nanotechnology (2005c), 'About', accessed at www.icon.rice.edu.about.cfm?doc_id4383, 14 June 2006.
53. International Organization for Standardization (2005a), 'New ISO committee will develop standards for nanotechnologies', accessed at www.iso.org, 19 December.
54. International Organization for Standardization (2005b), 'ISO launches work on nanotechnology standards', accessed at www.iso.org, 16 December.
55. International Organization for Standardization (2005c), 'TC 229 - Nanotechnologies', accessed at www.iso.org/eso/en/stdsdvelopment/tc/tclist/ TechnicalCommittee, 16 June 2006.
56. International Risk Governance Council (2006a), White Paper on Nanotechnology Risk Governance - Towards and Integrative Approach, Geneva: IRGC.
57. International Risk Governance Council (2006b), Survey on Nanotechnology Governance: Volume A. The Role of Government, Geneva: IRGC.
58. International Risk Governance Council (2006c), Survey on Nanotechnology Governance: Volume B. The Role of Industry, Geneva: IRGC.
59. International Risk Governance Council (2006d), Survey on Nanotechnology Governance: Volume C. The Role of Risk Research, Geneva: IRGC.
60. International Risk Governance Council (2006e), Survey on Nanotechnology Governance: Volume D. The Role of NGOs, Geneva: IRGC.
61. Kanavos, P. and E. Mossialos (1999), 'Outstanding regulatory aspects in the European pharmaceutical market', Pharmacoeconomics, 15 (6), 519-33.
62. Karlsson, S. I. (2004), 'Institutionalized knowledge challenges in pesticide governance: the end of knowledge and beginning of values in governing globalized environmental issues', International Environmental Agreements: Politics, Law and Economics, 4, 195-213.
63. Kearnes, M., P. MacNaghten and J. Wildson (2006), Governing at the Nanoscale: People, Policies and Emerging Technologies, London: Demos.
64. KEMI (1991), Risk Reduction of Chemicals: Report No 1/91, Stockholm: KEMI.
65. Kirkbride, J. and S. Letza (2004), 'Regulation, governance and regulatory collibration: achieving an "holistic" approach', Corporate Governance, 12 (1), 85-92.
66. Knill, C. and D. Lehmkuhl (2002), 'Private actors and the state: internationalization and changing patterns of governance', Governance: An International Journal of Policy and Administration, 15 (1), 41-63.
67. Krupp, F. and C. Holliday (2005), 'Let's get nanotech right',Wall Street Journal, 14 June, B2.
68. Lee, P. R. and J. Herzstein (1986), 'International drug regulation', Annual Review of Public Health, 7, 217-35.
69. Leyshon, A. (1992), 'The transformation of regulatory order: regulating the global economy and environment', Geoforum, 23 (3), 249-67.
70. L'Oréal (2006), 2005 Annual Report, Paris: L'Oréal.
71. Lux Research Inc (2005), 'Nanotechnology: where does the US stand?', in Testimony before the Research Subcommittee of the House Committee on Science, New York: Lux Research Inc.
72. Maskus, K. E. (1997), 'The international regulation of intellectual property', paper presented at the IESG Conference on Regulation of International Trade and Investment, University of Nottingham.
73. Maskus, K. E. (1998), 'The international regulation of intellectual property', Weltwirtschaftliches Archiv, 123 (2), 186-208.
74. Maynard, A. D. and J. A. Moore (2005), 'Project on emerging nanotechnologies: a partnership of the Woodrow Wilson International Center for Scholars and the Pew Charitable Trusts', presentation at the UK/Japan Workshop on Health, Environmental and Societal Issues of Nanotechnologies, London: Royal Society and Science Council of Japan.
75. Mehta, M. D. (2004), 'From biotechnology to nanotechnology: what can we learn from earlier technologies?', Bulletin of Science, Technology & Society, 24 (1), 34-9.
76. Meridian Institute and National Science Foundation (2004), International Dialogue on Responsible Research and Development of Nanotechnology, Alexandria, VA: Meridian Institute and NSF.
77. Miles, J. (2007), 'Metrology and standards for nanotechnology', Chapter 16, this volume.
78. Monica, J. C.,M. E. Heintz and P. T. Lewis (2007), 'The perils of pre-emptive regulation', Nature Nanotechnology, 2, 68-70.
79. nanoMark (2004), About nanoMark, Taipei: Industrial Technology Research Institute, accessed at www.nanomark.itri.org.tw/Eng/, 15 September 2006.
80. Nightengale, S. (1981), 'Drug regulation and policy formulation', Milbank Memorial Fund Quarterly Health and Society, 59 (3), 412-44.
81. OECD (2005a), 'The OECD: what is it?', accessed at www.oced.org, 21 December.
82. OECD (2005b), 'OCED workshop on the safety of manufactured nanomaterials: building cooperation, coordination and communication', joint meeting of the Chemicals Committee and Working Party on Chemicals, Pesticides and Biotechnology, OECD, Paris.
83. OECD (2006a), Report on the OECD Workshop on the Safety of Manufactured Nanomaterials: Building Co-operation, Co-ordination and Communication, Paris: Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology, OECD.
84. OECD (2006b), Manufactured Nanomaterials:Work Programme 2006-2008, Paris: Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology, OECD.
85. Procter & Gamble (2006), 2006 Annual Report, Cincinnti, OH: Procter & Gamble.
86. Renn, O. and M. C. Roco (2006), 'Nanotechnology and the need for risk governance', Journal of Nanoparticle Research, 8, 153-91.
87. Roco, M. C. (2004), 'The US National Nanotechnology Initiative after 3 years (2001-2003)', Journal of Nanoparticle Research, 6, 1-10.
88. Roco, M. C. (2005), 'The emergence and policy implications of converging new technologies integrated from the nanoscale', Journal of Nanoparticle Research, 7, 129-43.
89. Roco,M. C. and W. S. Bainbridge (eds) (2001), Societal Implications of Nanoscience and Nanotechnology, New York: Springer.
90. Stewart, P. A. and A. J. Knight (2005), 'Trends affecting the next generation of US agricultural biotechnology: politics, policy, and plant-made pharmaceuticals', Technological Forecasting & Social Change, 72, 521-34.
91. Tomellini, R. (2004), International Dialogue on Responsible Research and Development of Nanotechnology, 17-18 June, Alexandria, VA: IDRRDN.
92. United Nations Conference on Trade and Development (UNCTD) and International Centre for Trade and Sustainable Development (ICTSD) (2003), Intellectual Property Rights, Implications for Development Policy Discussion Paper, Geneva: UNCTAD and ICTSD.
93. US Patent Trade Office (US PTO) (2004a), 'New cross-reference digest for nanotechnology', accessed at www.uspto.gov/web/patents/biochempharm/crossref/ htm, 2 January 2006.
94. US Patent Trade Office (US PTO) (2004b), 'Class 977, nanotechnology', accessed at www.uspto.gov, 16 December 2005.
95. German Association of Research Based Pharmaceutical Companies (VFA) (2006), 2006 Statistics - Pharmaceutical Market, Germany: VFA accessed at www.vfa.de/en/statistics/harmaceuticalmarket, 1 November.
96. Visser, R. (2007), 'A sustainable development for nanotechnologies: an OECD perspective', Chapter 15, this volume.
97. Weiss, R. (2005), 'Nanotechnology regulation needed, critics say', Washingtonpost.com, accessed at www.washingtonpost.com, 5 December.
98. Wiktorowicz, M. (2003), 'Emergent patterns in the regulation of pharmaceuticals: institutions and interests in the United States, Canada, Britain, and France', Journal of Health Politics, Policy and Law, 28 (4), 615-58.
99. Wilsdon, J. and R. Willis (2004), See-through Science - Why Public Engagement Needs to Move Upstream, London: Demos.
100. Wilsdon, J., B. Wynne and J. Stilgoe (eds) (2005), The Public Value of Science: Or How to Ensure that Science Really Matters, London: Demos.